Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guber

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Muscle & Nerve|September 7, 2017
Patient-identified impact of symptoms in spinal and bulbar muscular atrophyRobert D Guber, Angela D Kokkinis, Alice B Schindler, et al.
Neurology|November 17, 2017
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophyRobert D Guber, Varun Takyar, Angela Kokkinis, et al.
Cell Metabolism|July 29, 2014
The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolismHaibo Sha, Shengyi Sun, Adam B Francisco, et al.
Molecular Cell|February 4, 2018
Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene PromotersChristopher Grunseich, Isabel X Wang, Jason A Watts, et al.
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.
Nature Cell Biology|November 10, 2015
IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradationShengyi Sun, Guojun Shi, Haibo Sha, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Muscle & Nerve|September 7, 2017
Patient-identified impact of symptoms in spinal and bulbar muscular atrophyRobert D Guber, Angela D Kokkinis, Alice B Schindler, et al.
Neurology|November 17, 2017
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophyRobert D Guber, Varun Takyar, Angela Kokkinis, et al.
Cell Metabolism|July 29, 2014
The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolismHaibo Sha, Shengyi Sun, Adam B Francisco, et al.
Molecular Cell|February 4, 2018
Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene PromotersChristopher Grunseich, Isabel X Wang, Jason A Watts, et al.
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.
Nature Cell Biology|November 10, 2015
IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradationShengyi Sun, Guojun Shi, Haibo Sha, et al.
Pageof 2